We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock

Delisted

OCEA was delisted on the 23rd of April, 2025.

46 hedge funds and large institutions have $17.1M invested in Ocean Biomedical, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

459% more capital invested

Capital invested by funds: $3.06M → $17.1M (+$14.1M)

259% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $645K

220% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 5

31% more funds holding

Funds holding: 3546 (+11)

56% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 16

Holders
46
Holders Change
+11
Holders Change %
+31.43%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
7
Reduced
16
Closed
5
Calls
$2.31M
Puts
$645K
Net Calls
+$1.67M
Net Calls Change
+$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
26
Barclays
United Kingdom
$23.6K -$12.1K -6,428 -51%
AIG
27
American International Group
New York
$16.2K -$70 -37 -0.9%
Wells Fargo
28
Wells Fargo
California
$11.7K +$737 +392 +15%
Fidelity Investments
29
Fidelity Investments
Massachusetts
$11.6K -$6.93K -3,688 -55%
Citigroup
30
Citigroup
New York
$9.11K +$1.92K +1,020 +73%
Russell Investments Group
31
Russell Investments Group
United Kingdom
$5.53K +$2.75K +1,460 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$3.73K -$833 -443 -31%
Legal & General Group
33
Legal & General Group
United Kingdom
$3.14K
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$2.89K +$1.44K +764 New
AIP
35
Ameritas Investment Partners
Nebraska
$2.71K
HT
36
Headlands Technologies
Illinois
$1.17K +$579 +308 New
Osaic Holdings
37
Osaic Holdings
Arizona
$1.14K
Citadel Advisors
38
Citadel Advisors
Florida
$1.14K +$564 +300 New
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$1K -$8.99K -4,785 -96%
AB
40
Amalgamated Bank
New York
$1K -$872 -464 -61%
AW
41
Avion Wealth
Texas
$1K +$231 +123 New
FFA
42
Farther Finance Advisors
California
$918 +$479 +255 New
CSC
43
Caldwell Sutter Capital
California
$379 +$188 +100 New
AWM
44
Avior Wealth Management
Nebraska
$7 +$4 +2 New
FIA
45
FNY Investment Advisers
New York
$2 +$1.13K +600 New
MC
46
Meteora Capital
Florida
-$375K -568,398 Closed
WC
47
Wexford Capital
Florida
-$22K -33,310 Closed
Two Sigma Investments
48
Two Sigma Investments
New York
-$16.8K -25,512 Closed
VF
49
Virtu Financial
New York
-$15K -23,179 Closed
Simplex Trading
50
Simplex Trading
Illinois
-$10.2K -5,402 Closed

OCEA Hedge Fund Activity: Q1 2024 in Review

46 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2024, worth a combined $17.1M — up 459% from $3.06M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new OCEA positions and 5 closed out — a net gain of 11 holders — while 7 added to existing stakes and 16 trimmed.

The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $461K. The largest seller was Meteora Capital, exiting entirely with an estimated $375K sold.

  • 46 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2024, up from 35 in Q4 2023.
  • Funds reported $17.1M of Ocean Biomedical, Inc. Common Stock stock for Q1 2024, up 459% quarter-over-quarter.
  • 16 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2024 and 5 closed out, a net change of +11 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2024 was OMERS Administration Corp, an estimated $461K added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2024 was Meteora Capital, an estimated $375K sold.

Based on aggregated 13F filings for Q1 2024.